Clinical characteristics and survival of BRAF-mutant (BRAF+) metastatic melanoma patients (pts) treated with BRAF inhibitor (BRAFi) dabrafenib or vemurafenib beyond disease progression (PD)

Matthew Chan; Lauren Haydu; Alexander M. Menzies; Mary W. F. Azer; Oliver Klein; Alexander Guminski; Richard Kefford; Georgina Long

doi:10.1200/jco.2013.31.15_suppl.9062

Clinical characteristics and survival of BRAF-mutant (BRAF+) metastatic melanoma patients (pts) treated with BRAF inhibitor (BRAFi) dabrafenib or vemurafenib beyond disease progression (PD)

Matthew Chan, Lauren Haydu, Alexander M. Menzies, Mary W. F. Azer, Oliver Klein, Alexander Guminski, Richard Kefford, Georgina Long

Faculty of Medicine, Health and Human Sciences

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	9062-9062
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	31
Issue number	15
DOIs	https://doi.org/10.1200/jco.2013.31.15_suppl.9062
Publication status	Published - 20 May 2013
Event	Annual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States Duration: 31 May 2013 → 4 Jun 2013

Access to Document

10.1200/jco.2013.31.15_suppl.9062

Cite this

Chan, M., Haydu, L., Menzies, A. M., Azer, M. W. F., Klein, O., Guminski, A., Kefford, R., & Long, G. (2013). Clinical characteristics and survival of BRAF-mutant (BRAF+) metastatic melanoma patients (pts) treated with BRAF inhibitor (BRAFi) dabrafenib or vemurafenib beyond disease progression (PD). Journal of Clinical Oncology, 31(15), 9062-9062. https://doi.org/10.1200/jco.2013.31.15_suppl.9062

Chan, Matthew ; Haydu, Lauren ; Menzies, Alexander M. ; Azer, Mary W. F. ; Klein, Oliver ; Guminski, Alexander ; Kefford, Richard ; Long, Georgina. / Clinical characteristics and survival of BRAF-mutant (BRAF+) metastatic melanoma patients (pts) treated with BRAF inhibitor (BRAFi) dabrafenib or vemurafenib beyond disease progression (PD). In: Journal of Clinical Oncology. 2013 ; Vol. 31, No. 15. pp. 9062-9062.

@article{2c5e39e724d343c0b82e5942341ae36b,

title = "Clinical characteristics and survival of BRAF-mutant (BRAF+) metastatic melanoma patients (pts) treated with BRAF inhibitor (BRAFi) dabrafenib or vemurafenib beyond disease progression (PD)",

author = "Matthew Chan and Lauren Haydu and Menzies, {Alexander M.} and Azer, {Mary W. F.} and Oliver Klein and Alexander Guminski and Richard Kefford and Georgina Long",

year = "2013",

month = may,

day = "20",

doi = "10.1200/jco.2013.31.15_suppl.9062",

language = "English",

volume = "31",

pages = "9062--9062",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

publisher = "American Society of Clinical Oncology",

number = "15",

note = "Annual Meeting of the American Society of Clinical Oncology (ASCO) ; Conference date: 31-05-2013 Through 04-06-2013",

}

Chan, M, Haydu, L, Menzies, AM, Azer, MWF, Klein, O, Guminski, A, Kefford, R & Long, G 2013, 'Clinical characteristics and survival of BRAF-mutant (BRAF+) metastatic melanoma patients (pts) treated with BRAF inhibitor (BRAFi) dabrafenib or vemurafenib beyond disease progression (PD)', Journal of Clinical Oncology, vol. 31, no. 15, pp. 9062-9062. https://doi.org/10.1200/jco.2013.31.15_suppl.9062

Clinical characteristics and survival of BRAF-mutant (BRAF+) metastatic melanoma patients (pts) treated with BRAF inhibitor (BRAFi) dabrafenib or vemurafenib beyond disease progression (PD). / Chan, Matthew; Haydu, Lauren; Menzies, Alexander M.; Azer, Mary W. F.; Klein, Oliver; Guminski, Alexander; Kefford, Richard; Long, Georgina.

In: Journal of Clinical Oncology, Vol. 31, No. 15, 20.05.2013, p. 9062-9062.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Clinical characteristics and survival of BRAF-mutant (BRAF+) metastatic melanoma patients (pts) treated with BRAF inhibitor (BRAFi) dabrafenib or vemurafenib beyond disease progression (PD)

AU - Chan, Matthew

AU - Haydu, Lauren

AU - Menzies, Alexander M.

AU - Azer, Mary W. F.

AU - Klein, Oliver

AU - Guminski, Alexander

AU - Kefford, Richard

AU - Long, Georgina

PY - 2013/5/20

Y1 - 2013/5/20

U2 - 10.1200/jco.2013.31.15_suppl.9062

DO - 10.1200/jco.2013.31.15_suppl.9062

M3 - Meeting abstract

VL - 31

SP - 9062

EP - 9062

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 1527-7755

IS - 15

T2 - Annual Meeting of the American Society of Clinical Oncology (ASCO)

Y2 - 31 May 2013 through 4 June 2013

ER -